Latest news
Loading news…
Omthera Pharmaceuticals
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Princeton, New Jersey, United States Founded 2008 11-50 employees For Profit
Omthera Pharmaceuticals develops therapies for patients with elevated triglyceride levels and increased risk of cardiovascular disease.
Omthera Pharmaceuticals was acquired by AstraZeneca in 2013 for $323M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- OMTH
- Exchange
- NASDAQ
- IPO date
- Apr 11, 2013
- Raised at IPO
- $64M
- Delisted
- Jul 18, 2013
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 16
- Active products
- 2
Company Info
- Founded
- 2008
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 2
- HQ
- Princeton, New Jersey, United States
- Region
- East Coast, Northeastern US
- Exit date
- Apr 11, 2013
- Closed
- Jul 19, 2013
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- 0.6
- Trend (90d)
- 1.9
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Omthera Pharmaceuticals
Loading news…
FAQs about Omthera Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.